Article
Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis - 1 Jan 2000
Varagunam Mira, McCloskey Daniel J, Sinnott Paul J, Raftery Martin J, Yaqoob Muhammed M
Abstract excerpt
OBJECTIVES: To study the effect of angiotensin-converting enzyme (ACE) polymorphisms II, ID, and DD on erythropoietin (EPO) requirement in patients on continuous ambulatory peritoneal dialysis (CAPD) therapy. DESIGN: Retrospective observational study. SETTING: CAPD Unit, Royal London/St. Bartholomews Hospital, London, UK. PATIENTS: 46 patients on the transplant waiting list (age 20-70 years), on CAPD therapy for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
